Allergan begins trials on hair-growth drug
Drugmaker Allergan is recruiting volunteers for clinical trials of a hair-growth treatment based on the active ingredient in Latisse (bimatoprost ophthalmic solution, 0.03 percent), the company’s eyelash-growth treatment. (Source: Modern Medicine)
See more here:
Allergan begins trials on hair-growth drug
Comments
Leave a Reply
